Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments

Introduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from th...

Full description

Bibliographic Details
Main Authors: Fanyu Meng, Haoyun Zhang, Haiwen Peng, Shichun Lu
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/6638117
id doaj-9c851280a8d54eb88e21f6cb26e126b5
record_format Article
spelling doaj-9c851280a8d54eb88e21f6cb26e126b52021-06-14T00:17:30ZengHindawi LimitedBioMed Research International2314-61412021-01-01202110.1155/2021/6638117Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different TreatmentsFanyu Meng0Haoyun Zhang1Haiwen Peng2Shichun Lu3Department of Hepatobiliary SurgeryDepartment of Hepatobiliary SurgeryDepartment of Orthopedics SurgeryDepartment of Hepatobiliary SurgeryIntroduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from the Surveillance Epidemiology and End Results (SEER) database were included. Patients survived ≥10 years, and patients died <10 years were compared. Significant predictors associated with 10-year survival were identified by multivariate logistic regression analysis. The 10-year survival outcomes of 3 treatments were compared using multivariate model risk adjustment and inverse probability of treatment weighted (IPTW) adjustment. Results. Of the 1255 patients, 472 patients underwent SR, 259 patients underwent LT, and 524 patients underwent RFA. 149 patients achieved 10-year survival. Multivariate logistic regression analysis showed that age, race, treatment, and fibrosis score were significant predictors for 10-year survival, and LT had the best advantage of 10-year survival, followed by SR. Comparable 10-year survival outcomes were found between SR and RFA after IPTW. Then, a subgroup analysis was performed based on the tumor size, and the results showed that for ≤50 mm tumor, SR showed no significant advantages over RFA for 10-year survival. Conclusions. Estimates of the observational association of different treatments with 10-year survival are sensitive to the analytic method. LT showed the best outcomes for patients. No significant differences for 10-year survival were found between SR and RFA in the IPTW cohort. Subgroup analysis showed that for >50 mm tumor, SR showed significant advantages over RFA after IPTW.http://dx.doi.org/10.1155/2021/6638117
collection DOAJ
language English
format Article
sources DOAJ
author Fanyu Meng
Haoyun Zhang
Haiwen Peng
Shichun Lu
spellingShingle Fanyu Meng
Haoyun Zhang
Haiwen Peng
Shichun Lu
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
BioMed Research International
author_facet Fanyu Meng
Haoyun Zhang
Haiwen Peng
Shichun Lu
author_sort Fanyu Meng
title Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
title_short Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
title_full Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
title_fullStr Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
title_full_unstemmed Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
title_sort comparison of 10-year survival outcomes for early single hepatocellular carcinoma following different treatments
publisher Hindawi Limited
series BioMed Research International
issn 2314-6141
publishDate 2021-01-01
description Introduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from the Surveillance Epidemiology and End Results (SEER) database were included. Patients survived ≥10 years, and patients died <10 years were compared. Significant predictors associated with 10-year survival were identified by multivariate logistic regression analysis. The 10-year survival outcomes of 3 treatments were compared using multivariate model risk adjustment and inverse probability of treatment weighted (IPTW) adjustment. Results. Of the 1255 patients, 472 patients underwent SR, 259 patients underwent LT, and 524 patients underwent RFA. 149 patients achieved 10-year survival. Multivariate logistic regression analysis showed that age, race, treatment, and fibrosis score were significant predictors for 10-year survival, and LT had the best advantage of 10-year survival, followed by SR. Comparable 10-year survival outcomes were found between SR and RFA after IPTW. Then, a subgroup analysis was performed based on the tumor size, and the results showed that for ≤50 mm tumor, SR showed no significant advantages over RFA for 10-year survival. Conclusions. Estimates of the observational association of different treatments with 10-year survival are sensitive to the analytic method. LT showed the best outcomes for patients. No significant differences for 10-year survival were found between SR and RFA in the IPTW cohort. Subgroup analysis showed that for >50 mm tumor, SR showed significant advantages over RFA after IPTW.
url http://dx.doi.org/10.1155/2021/6638117
work_keys_str_mv AT fanyumeng comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments
AT haoyunzhang comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments
AT haiwenpeng comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments
AT shichunlu comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments
_version_ 1721378833415798784